publication venue for
- Economic implications of IGT intervention: The case of a 'phantom alternative' 1996
- Cost effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE)-A randomised placebo-controlled clinical trial.. e70036. 2025
- An audit and feedback-based intervention to improve diabetes management in the year after transfer to adult type 1 diabetes care: A multi-center quasi-experimental study.. 42:e15444. 2025
- Demystifying diabetes health coaching: A scoping review unveiling the ‘who’ and ‘where’ of health coaching for adults with type 2 diabetes. 41:e15327. 2024
- Out of the mouths of Peer Leaders: Perspectives on how to improve a telephone‐based peer support intervention in type 2 diabetes. 39:e14853. 2022
- A study of diabetic ketoacidosis in the pregnant population in the United Kingdom: Investigating the incidence, aetiology, management and outcomes. 39:e14743. 2022
- The top 10 research priorities in diabetes and pregnancy according to women, support networks and healthcare professionals. 38:e14588. 2021
- Management of type 2 diabetes using non‐insulin glucose‐lowering therapies: a critical appraisal of clinical practice guidelines with the AGREE II instrument. 37:636-647. 2020
- Seasonal variation in hospital encounters with hypoglycaemia and hyperglycaemia. 34:958-965. 2017
- A systematic review of interventions to improve outcomes for young adults with Type 1 diabetes. 34:753-769. 2017
- Effect of a structured diabetes education programme in primary care on hospitalizations and emergency department visits among people with Type 2 diabetes mellitus: results from the Patient Empowerment Programme. 33:1427-1436. 2016
- Impact of diabetes on healthcare costs in a population‐based cohort: a cost analysis. 33:395-403. 2016
- Diabetes self‐management programmes in older adults: a systematic review and meta‐analysis. 32:1404-1414. 2015
- Condition‐related predictors of successful transition from paediatric to adult care among adolescents with Type 1 diabetes. 32:881-885. 2015
-
Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub‐study of the
DREAM trial. 31:1086-1092. 2014 - Trends in selection and timing of first‐line pharmacotherapy in older patients with Type 2 diabetes diagnosed between 1994 and 2006. 30:1209-1213. 2013
- Realist review to understand the efficacy of culturally appropriate diabetes education programmes. 30:1017-1025. 2013
- Can computerized clinical decision support systems improve diabetes management? A systematic review and meta‐analysis. 30:739-745. 2013
- Progression through diabetes therapies among new elderly users of metformin: a population‐based study. 30:e51-e55. 2013
- Increased cardiovascular risk after pre‐eclampsia in women with dysglycaemia. 30:e1-e7. 2013
- Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. 27:1226-1232. 2010
- Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes. 27:175-180. 2010
- Diabetes care in rest homes in Christchurch, New Zealand. 23:1252-1256. 2006
- A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose‐lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study. 23:736-742. 2006
- Hyperglycaemia and mortality of diabetic patients with candidaemia. 22:1252-1257. 2005
- Oxidative stress and glucose levels in a population‐based sample. 21:1346-1352. 2004
- Pre‐prandial vs. post‐prandial capillary glucose measurements as targets for repaglinide dose titration in people with diet‐treated or metformin‐treated Type 2 diabetes: a randomized controlled clinical trial. 21:1200-1203. 2004
- The GP perspective: problems experienced in providing diabetes care in UK general practice. 19:13-20. 2002
- General description and methods. 19:13-14. 2002
- Lighting up insulin action.. 18:253-260. 2001
- A controlled evaluation of a national continuing medical education programme designed to improve family physicians’ implementation of diabetes‐specific clinical practice guidelines. 16:964-969. 1999
- Limited joint mobility in the hands and feet of adolescents with Type 1 diabetes mellitus. 16:125-130. 1999
- Glucose: a Continuous Risk Factor for Cardiovascular Disease. 14:S25-S31. 1997
- Economic implications of IGT intervention: the case of a "phantom alternative'?. 13:S25-S28. 1996
- The Relationship Between Cow’s Milk Exposure and Type 1 Diabetes. 13:23-29. 1996